EXPAREL is a Infiltration Injection, Suspension, Liposomal in the Human Prescription Drug category. It is labeled and distributed by Pacira Pharmaceuticals Inc.. The primary component is Bupivacaine.
| Product ID | 65250-266_23030401-c18b-4366-b87d-addbe252269b |
| NDC | 65250-266 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EXPAREL |
| Generic Name | Bupivacaine |
| Dosage Form | Injection, Suspension, Liposomal |
| Route of Administration | INFILTRATION |
| Marketing Start Date | 2012-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022496 |
| Labeler Name | Pacira Pharmaceuticals Inc. |
| Substance Name | BUPIVACAINE |
| Active Ingredient Strength | 13 mg/mL |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2016-09-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022496 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-09-28 |
| Marketing Category | NDA |
| Application Number | NDA022496 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-01-01 |
| Marketing Category | NDA |
| Application Number | NDA022496 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-03-31 |
| Ingredient | Strength |
|---|---|
| BUPIVACAINE | 13.3 mg/mL |
| SPL SET ID: | bb5a9e59-0f51-11df-8a39-0800200c9a66 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 65250-133 | EXPAREL | bupivacaine |
| 65250-266 | EXPAREL | bupivacaine |
| 49396-6601 | POSIMIR | Bupivacaine |
| 51715-660 | POSIMIR | bupivacaine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EXPAREL 77464815 4074454 Live/Registered |
Pacira Pharmaceuticals, Inc. 2008-05-02 |